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1. Introduction 
Studies on the /3-adrenergic agonist-stimulated 
turkey erythrocyte adenylate cyclase indicated that a 
GTPase activity associated with the guanine nucleo- 
tide-binding regulatory subunit (N) leads to the inac- 
tivation of the hormone-stimulated adenylate cyclase 
by hydrolysis of N-bound GTP to GDP and Pi [ 1,2]. 
This model was validated by the finding that treat- 
ment of the membranes with cholera toxin, which 
almost abolishes the difference between GTP and its 
poorly hydrolyzable analogs in adenylate cyclase 
activation, causes a concomitant inhibition of the 
hormone-stimulated GTPase activity [3]. In various 
tissues and with various hormonal factors that inhibit 
adenylate cyclase, it has been shown that the negative 
hormonal control of adenylate cyclase activity in 
cell-free systems requires the presence of GTP [4,5], 
as is known for hormonal stimulation of the enzyme 
[6]. However, in contrast to hormonal stimulation, 
which is usually potentiated by stable GTP analogs 
[6], these analogs prevented or reversed hormonal 
inhibition [4,5,7,8]. Therefore, it has been suggested 
[4,7] that inhibitory hormones may decrease adenyl- 
ate cyclase activity by accelerating the off-rate of the 
active adenylate cyclase via an increase in GTPase 
activity. In membrane preparations ofhuman platelets, 
whose adenylate cyclase is inhibited by a-adrenergic 
agonists in a GTP-dependent manner [9], we studied 
the influence of epinephrine on GTPase activity and 
we report here that epinephrine inhibits adenylate 
cyclase and stimulates a low Km GTPase via cy-adren- 
oceptors in this system. 
2. Materials and methods 
Materials used were essentially as in [9]. [o(-~~P]- 
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ATP and [y-32P]GTP were prepared according to 
[IO]. Lysates of human platelets, obtained by rapid 
freezing and prior to assay thawing in 10 mM trieth- 
anolamine-HCl, pH 7.4, containing 5 mM EDTA, 
were centrifuged for 20 min at 30 000 X g at 4°C. 
The pellet was washed twice in the same medium and 
finally suspended in 10 mM triethanolamine-HCl, 
pH 7.4, without EDTA. Adenylate cyclase activity 
was determined with 0.1 mM [(Y-~~P]ATP (essentially 
GTP-free; 0.3-0.6 yCi per tube), 2 mM MgC12, 1 mM 
3-isobutyl-1 -methylxanthine, 0.1 mM cyclic AMP, 
5 mM creatine phosphate, 1.2 mg ml-’ creatine 
kinase, 0.2% bovine serum albumin, 1 mM dithio- 
threitol, 0.1 mM EDTA and 50 mM triethanolamine- 
HCl,pH7.4,inatotalvolumeofO.l ml.GTP(0.3pM) 
and d,Z-propranolol(30 FM) were included under 
each condition. Reactions were initiated by the addi- 
tion of platelet particles (40-70 pg protein) and 
allowed to proceed for 10 min at 25°C. The cyclic 
AMP formed was purified as in [ 111. GTPase activity 
was determined according to [ 11, with the same reac- 
tion mixture as described above for the determina- 
tion of adenylate cyclase activity, with the exception 
that unlabeled ATP (0.1 mM) and [-Y-~~P]GTP (0.08- 
0.2 &i per tube; 0.3 PM or at the indicated concen- 
tration) were present. Reactions were initiated by the 
addition of platelet particles (4-l 0 & protein), and 
continued for 10 min or as indicated at 2S”C, and 
terminated by the addition of 0.5 ml ice-cold sodium 
phosphate buffer (20 mM), pH 7.0, containing 5% 
(w/v) activated charcoal. The reaction tubes were 
centrifuged for 10 min at 10 000 X g at 4”C, and 
0.4 ml of the supernatant was transferred into scintil- 
lation vials. Radioactivity was counted using Cerenkov 
radiation. Release of 32Pi from [Y-~~P] GTP in the 
absence of membranes was 0.5-3% of added [Y-~~P]- 
GTP. All reactions were performed in triplicate with 
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an intraassay variation of less than 5%. Results similar 
to those shown here were obtained in repeated exper- 
iments. 
3. Results 
Hydrolysis of [Y-~‘P] GTP was potently reduced 
by low concentrations of unlabeled GTP, as shown by 
the isotope dilution curve (fig.1, left). This finding 
indicated that a low Km GTPase was mainly respon- 
sible for GTP hydrolysis in human platelet membrane 
preparations. However, the curvilinearity of the 
Lineweaver-Burk diagram (fig.1, right) suggests that 
at least two enzymes with different affinities for the 
substrate, GTP, were involved in [y-32P]GTP hydro- 
lysis. From the linear portion of the Lineweaver-Burk 
graph an apparent Km value of 0.3-0.4 FM GTP was 
extrapolated for a GTPase with high affinity for GTP. 
Addition of the ATP analog, adenylyl-5’-imidodiphos- 
phate, up to 1 mM, to the GTPase assay medium did 
not decrease the activity of the high Km GTPase(s) as 
has been reported in turkey erythrocytes [ 11. 
In the presence of 0.3 PM GTP, epinephrine inhib- 
ited adenylate cyclase in human platelet membranes 
by a maximum of 60-70% at 30 PM; half-maximal 
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Fig.2. Influence of epinephrine on human platelet adenylate 
cyclase and GTPase activities. Activity of adenylate cyclase 
(o), indicated on the left ordinate, and activity of the GTPase 
(a), indicated on the right ordinate, were determined at 
increasing concentrations of epinephrine. GTP concentration 
was 0.3 PM. 
GTP (uM)-’ 
Fig.1. Hydrolysis of [y-32P]GTP by human platelet particles at various concentrations of GTP. Increasing concentrations of unla- 
beled GTP were added to a constant amount of labeled [r-“P]GTP to give the final concentration indicated on the abscissa. Left 
panel: Isotope dilution curve of GTP hydrolysis with percent of [y-3ZP]GTP hydrolyzed indicated on the ordinate. Right panel: 
Lineweaver-Burk plot of GTP hydrolysis. The apparent Km value (0.3-0.4 PM) of a GTPase with a high affinity for GTP was 
extrapolated from the linear part of the curve. 
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inhibition was observed at 0.5-l PM epinephrine 
(fig.2). Under the same assay conditions, epinephrine 
increased the activity of the GTPase in a concentration- 
dependent manner. Maximal stimulation of the GTPase 
was observed at IO-30 fl and h~f-mammal stimula- 
tion at about 1 PM epinephrine. Shown in Gg.3 is the 
influence of epinephrine (300 ,uM) on GTPase activity 
at increasing concentrations of GTP. The stimulation 
of the GTPase by epinephrine was half-maximal and 
maximal at about 0.3 and 1-3 I.IM GTP. 
The increase in GTP hydrolysis induced by epineph- 
rine occurred without an apparent lag phase and was 
linear for at least up to 10 min ffig.4, left). The cr-adren- 
ergic antagonist, phentolamine (30pM), added together 
with epinephrine (100 PM), or 6 min after the reac- 
tion had been started, abolished the epinephrine 
effect on the GTPase activity without an apparent 
lag period. Prostaglandin (PG) El, which causes maxi- 
mal stimulation of platelet adenylate cyclase (about 
20-fold) [9,1 I], also increased the hydrolysis of 
[Y-~*P] GTP. Maximal activation of GTPase induced 
by PGEr (1 @) was always less than that induced by 
epinephrine at maximally effective concentrations. 
In the presence of PGEr (1 &MI), epinephrine (100 PM) 
caused a further increase in GTP hydrolysis (fig.4, 
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Fig.3. Influence of epinephrine on the rate of GTP hydrolysis 
at various GTP concentrations. GTP hydrolysis was deter- 
mined with varying concentrations of GTP in the absence (o) 
and presence (0) of 300 FM epinephrine as indicated. The 
inset shows the increment in GTPase activity caused by 
400 - 
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Fig.4. Time course of GTP hydrolysis in the absence and presence of epinephrine, phentolamine and PGE,. GTP concentration 
was 0.3 PM. Left panel: 0, control; o, 100 PM epineph~ne; 0, 100 pM epinephrine plus 30 PM phentolamine, added at zero time 
or 6 mm after the reaction has been started, as indicated by the arrow. Right panel: 0, control; v, 1 PM PGE,; l , 1 PM PGE, PIUS 
100 PM cpinephrine; n, 1 PM PGE, plus 100 J.IM epinephrine plus 30 FM phentolamine. 
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right). Phentolamine (30 PM) abolished this epineph- 
rine-induced increase in GTP breakdown, but did not 
affect the stimulation of GTPase by PGEr. 
4. Discussion 
In human platelet membrane preparations, epineph- 
rine, via a-adrenoceptors, inhibits adenylate cyclase 
by a GTP-dependent process, which is prevented or 
reversed by stable GTP analogs [7,9], as has been 
shown for various inhibitory hormones in different 
tissues [4,5 1. Based on these opposite actions of GTP 
and its stable analogs in hormone-induced adenylate 
cyclase inhibition, we previously suggested [4,7] that 
inhibitory hormones may decrease adenylate cyclase 
activity by increasing the off-rate of the system, which 
appears to be controlled by a GTPase activity associ- 
ated to the guanine nucleotide-binding regulatory 
subunit [l-3,6]. The data presented indicate that 
epinephrine increases the activity of a low Km GTP- 
ase in human platelet membrane preparations. The 
apparent Km of about 0.3 PM GTP is about 3-fold 
higher than that obtained for /3-adrenergic agonist- 
stimulated GTPase in turkey erythrocyte membranes 
[I]. This difference may be based on the different 
tissues studied, but may also reflect the finding in 
adenylate cyclase studies that in some tissues higher 
GTP concentrations were required for hormonal 
inhibition than for stimulation of adenylate cyclase 
[4,5]. The maximal increase in GTPase activity induced 
by epinephrine in the platelet system (20-30 pmol 
GTP hydrolyzed per mg protein and per min) is far 
higher than that reported for the isoproterenol-induced 
stimulation in turkey erythrocyte membranes (3-7 
pmol per mg and per min) [ I], PGE,, which stimulates 
platelet adenylate cyclase, also increased the GTPase 
activity, but not to the same extent as epinephrine, 
which inhibits the cyclase. 
There was a good correlation between the data 
obtained in adenylate cyclase and in GTPase activity 
studies. The concentrations of epinephrine required 
for half-maximal and maximal inhibition of the 
cyclase were almost identical to those required for 
half-maximal and maximal stimulation of the low Km 
GTPase. Additionally, half-maximal stimulation of 
the GTPase and inhibition of the adenylate cyclase 
[9] occurred at about 0.3 FM GTP. Furthermore, the 
epinephrine-induced stimulation of the GTPase was 
antagonized by the oc-adrenergic blocking agent, 
phentolamine, which also antagonizes epinephrine- 
23% 
induced inhibition of the platelet adenylate cyclase 
[ 111. This finding indicates that, similar to adenylate 
cyclase inhibition, stimulation of the GTPase by 
epinephrine is mediated by oc-adrenoceptors. 
Recently, we have found in studies on hamster 
adipocyte adenylate cyclase that inhibitory hormonal 
factors increase the off-rate of this enzyme and stim- 
ulate a low-K, GTPase in the same membrane system 
[12]. Therefore, we suggest hat in human platelet 
membranes stimulation of a GTPase is involved in 
adenylate cyclase inhibition by a-adrenergic agonists 
and that an acceleration of the turn-off reaction of 
the adenylate cyclase mediated by an increase in 
GTPase activity may be a feature common to hor- 
mone-induced adenylate cyclase inhibition. Further 
studies are required to elucidate which mechanism 
inhibitory hormones increase the GTPase activity, 
and whether the GTPase activated by stimulatory 
hormones is identical to that activated by inhibitory 
hormones. 
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